0001209191-18-057421.txt : 20181106 0001209191-18-057421.hdr.sgml : 20181106 20181106164537 ACCESSION NUMBER: 0001209191-18-057421 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181102 FILED AS OF DATE: 20181106 DATE AS OF CHANGE: 20181106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sachdev Amit CENTRAL INDEX KEY: 0001406338 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 181163593 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-11-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001406338 Sachdev Amit C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, CRO Common Stock 2018-11-02 4 M 0 2155 91.05 A 48817 D Common Stock 2018-11-02 4 S 0 600 171.93 D 48217 D Common Stock 2018-11-02 4 S 0 1255 172.81 D 46962 D Common Stock 2018-11-02 4 S 0 100 173.35 D 46862 D Common Stock 2018-11-02 4 S 0 100 175.31 D 46762 D Common Stock 2018-11-02 4 S 0 100 176.04 D 46662 D Common Stock 2018-11-05 4 M 0 1941 86.52 A 48603 D Common Stock 2018-11-05 4 S 0 300 172.70 D 48303 D Common Stock 2018-11-05 4 S 0 1213 173.74 D 47090 D Common Stock 2018-11-05 4 S 0 428 174.41 D 46662 D Common Stock 12215 I Held in Trust Common Stock 882 I 401(k) Stock Option (Right to Buy) 91.05 2018-11-02 4 M 0 2155 0.00 A 2026-02-01 Common Stock 2155 10777 D Stock Option (Right to Buy) 86.52 2018-11-05 4 M 0 1941 0.00 A 2027-02-02 Common Stock 1941 17475 D Transaction made pursuant to Mr. Sachdev's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $171.93 (range $171.25 to $172.24). Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $172.81 (range $172.32 to $173.27). Open market sales reported on this line occurred at a weighted average price of $172.70 (range $172.16 to $173.12). Open market sales reported on this line occurred at a weighted average price of $173.74 (range $173.28 to $174.15). Open market sales reported on this line occurred at a weighted average price of $174.41(range $174.31 to $174.50). The option vests in 16 quarterly installments from 2/2/2016. The option vests in 16 quarterly installments from 02/03/2017. /s/ Omar White, Attorney-in-Fact 2018-11-06